HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Clinical Expertise

“My research interest is in drug development, so I conduct early-phase clinical trials — which means first-in-human studies — in order to look for therapies with novel mechanisms of action to treat patients and improve their outcomes. Many multiple myeloma patients have side effects and toxicities from previous treatments, and they have poor quality of life because of symptoms of the disease. These patients need therapies that can be tolerated easily.”


The Ohio State University Comprehensive Cancer Center: 460 W 10th Ave, Columbus, OH 43210, USA

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube